Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and ...

While discussing the financial constraints of the vaccine industry, Poonawalla called for relaxing price caps to encourage ...

Health workers in the county are among 580 persons infected by Chikungunya virus thereby hampering ... 13 clinical officers and 23 support staff are affected and are currently under medication ...

He said globally, over one billion people are affected by NTDs across 149 countries with Africa bearing nearly half of the burden ...

At least one girl and three boys were killed, and three boys injured, during an attack on the Saudi Hospital in the besieged ...

This action follows an executive order signed by President Trump on his first day in office to withdraw the United States ...

Recent outbreak of Guillain–Barré syndrome in Pune causing panic, symptoms, diagnosis, treatment, and prevention explained in detail.

Specifically, Ixchiq will be tested in children aged one to 11 and pregnant women in countries that may be affected by a chikungunya outbreak, including Brazil, which is currently contending with ...

Climate change could wreak havoc on Britain in coming decades, with rising food poisoning, allergies and the arrival of ...